Skip to content

Prospective registry of STEMI management in Covid era -INDIA (PRESCO-INDIA) - A Cardiological Society of India Study

Prospective registry of STEMI management in Covid era -INDIA (PRESCO-INDIA)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/035295
Enrollment
3000
Registered
2021-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I20- Angina pectoris

Interventions

None listed

Sponsors

Cardiological Society of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive patients above 18 years of age with STEMI as per 4thuniversal definition of MI during the study period

Exclusion criteria

Exclusion criteria: Patients below 18 years, Patients not willing to give informed consent, Patients with life-threatening diseases like severe COVID 19 infection on ventilator, Terminal malignancy, Debilitating stroke and CKD patients on maintenance haemodialysis, MI/PCI/CABG within past 14 days of STEMI admission, Patients thrombolysed elsewhere, Patients enrolled in any other research studies

Design outcomes

Primary

MeasureTime frame
To study the initial treatment strategy employed for hospitalized patients with STEMI in India during the current COVID-19 pandemic and to document the differences in the primary outcome of death, re-infarction and stroke in-hospital and at 30 days post discharge based on the initial treatment strategy.Timepoint: 5 months or when target of 3000 patients are recruited which ever happens first

Secondary

MeasureTime frame
To evaluate the major in-hospital complications of STEMI patients in relation to the initial reperfusion strategy employed. To study the differences in left ventricular function(LVEF) assessed by echocardiography during hospital admission and at 30 days post discharge among STEMI patients treated with various reperfusion strategies. To study the time delay in the presentation of STEMI and the various reperfusion strategies employed. Timepoint: 5 months or when target of 3000 patients are recruited which ever happens first

Countries

India

Contacts

Public ContactDr Padhinhare P Mohanan

Director, Westfort Hi- Tech Hospital

csiamistudy@gmail.com9846076006

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026